Thomas Burke

Background

About Thomas Burke

A leader in the development of HEOR, value evidence, commercialization, and reimbursement strategies, I partner with internal and external resources and scientific leaders to guide innovative product development. I support the full spectrum of clinical, economic, and humanistic value evidence, leveraging a robust scientific background to bridge evidence gaps, develop new processes, and influence forward action to improve patient outcomes. Within Merck & Co. Inc, I have played a key role in the growth of the company's oncology therapeutic area with a focus on Keytruda and lung cancer. I strategically navigate launch activities while executing quality HEOR and market access deliverables, leading 11 total team members across six value evidence teams. As a leader, I foster cultures of transparency and trust. I ensure my teams are backed by resources and knowledge necessary for success while building a vision for the future and aligning to enterprise-wide objectives.Areas of Expertise: Oncology Therapeutic Areas Health Economics & Outcomes Research Value Evidence Generation Commercialization Strategies Global Clinical Development Health Technology Assessments Cross-Functional CollaborationCareer Highlights: Responsible for value evidence and market access strategy as a member of Merck’s lung cancer product development team that developed Keytruda in 5 indications. Spearheaded value evidence generation, supporting clinical trial development from early stages through to launch across the life cycle. Partnered to co-lead the company’s first EMA/HTA joint scientific advice contributing to early patient access and positive HTA appraisals for Keytruda in lung cancer Developed long-term RWD research collaborations in the US and Europe. Open to networking and connecting, I can be reach directly at thomasburke@ptd.net.